Updated Jun 18
Nov 10, 2026
Anthropic Launches Claude Fable 5.2 With 20% Price Cut Ahead of IPO
Anthropic released Claude Fable 5.2 and Mythos 5.2 on Monday, claiming the top spot on 13 of 15 benchmark score lines against GPT-6 Astra and Gemini 4 Carbon. The new models are 30% faster and 20% cheaper than their predecessors, priced at $8 per million input tokens — undercutting OpenAI's flagship. The launch comes days before Anthropic's blockbuster IPO and marks its first frontier release since CEO Dario Amodei called for a slowdown in AI development.
anthropicclaude-fable-5-2claude-mythos-5-2
Nov 9, 2026
OpenAI, Google, Microsoft, and Anthropic Back Unified AI Training Opt-Out in Robots.txt
The four largest Western AI labs will honor a single robots.txt policy token that lets website owners opt out of AI training across all their crawlers at once. Anthropic has already begun implementation; OpenAI, Google, and Microsoft follow in 2027.
robots-txtai-trainingweb-crawlers
Nov 8, 2026
Elvis Estate and Eminem Publisher Sue Suno in Escalating AI Music Copyright War
The rights holders for Elvis Presley and Eminem's publisher Eight Mile Style filed separate federal lawsuits against AI music generator Suno on Friday, alleging copyright infringement and violations of Tennessee's ELVIS Act. The twin filings mark one of the first major tests of the 2024 voice-cloning law and escalate an already intense legal battle between the music industry and AI companies.
sunoai-musiccopyright
Related News
Apr 5, 2026
Elon Musk's SpaceX IPO Gambit: A $1.75 Trillion Tech Twist with a Grok Surprise!
Elon Musk is shaking up the IPO landscape with SpaceX's anticipated colossal public offering, targeting a valuation over $1 trillion. But that's not all—the twist? Banks and advisors are being required to subscribe to 'Grok,' xAI's AI chatbot, as a part of their involvement. This move intertwines SpaceX's capital goals with boosting Grok's adoption in enterprise, presenting a bold strategy combining rockets with AI tech enhancements.
Elon MuskSpaceXIPO
Apr 4, 2026
Dataswap Drama: Health Data Debacle Between Perplexity AI and Claude AI Stirs Controversy
In a heated exchange that has captured tech and health-watchers' attention, Perplexity AI and Claude AI's alleged sharing of health data has sparked a maelstrom of public and regulatory scrutiny. Concerns over potential HIPAA violations, data security, and ethical considerations are at the forefront of the debate, as privacy advocates and tech enthusiasts clash over the implications of this data-swapping saga.
Perplexity AIClaude AIhealth data
Apr 3, 2026
Tesla's Tumultuous Year: Is It Time to Buy the Dip?
Tesla faces a rollercoaster year with mixed Q3 results, featuring record revenues and deliveries that beat expectations but a miss on EPS and declining profit margins. External pressures include regulatory scrutiny, analyst downgrades, and a Cybertruck recall. The question remains whether this dip is a buying opportunity amid ongoing valuation concerns and near-term risks.
TeslaTSLAstock market